321 related articles for article (PubMed ID: 25890327)
1. RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1-mediated modulation of the LPS-induced activation of BV-2 microglial cells.
Jung KH; Das A; Chai JC; Kim SH; Morya N; Park KS; Lee YS; Chai YG
J Neuroinflammation; 2015 Feb; 12():36. PubMed ID: 25890327
[TBL] [Abstract][Full Text] [Related]
2. Dual transcriptome sequencing reveals resistance of TLR4 ligand-activated bone marrow-derived macrophages to inflammation mediated by the BET inhibitor JQ1.
Das A; Chai JC; Yang CS; Lee YS; Das ND; Jung KH; Chai YG
Sci Rep; 2015 Nov; 5():16932. PubMed ID: 26582142
[TBL] [Abstract][Full Text] [Related]
3. Dual RNA sequencing reveals the expression of unique transcriptomic signatures in lipopolysaccharide-induced BV-2 microglial cells.
Das A; Chai JC; Kim SH; Park KS; Lee YS; Jung KH; Chai YG
PLoS One; 2015; 10(3):e0121117. PubMed ID: 25811458
[TBL] [Abstract][Full Text] [Related]
4. The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line.
Baek M; Yoo E; Choi HI; An GY; Chai JC; Lee YS; Jung KH; Chai YG
Sci Rep; 2021 Apr; 11(1):8828. PubMed ID: 33893325
[TBL] [Abstract][Full Text] [Related]
5. 6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation.
Huang HY; Chang HF; Tsai MJ; Chen JS; Wang MJ
J Neuroinflammation; 2016 Apr; 13(1):78. PubMed ID: 27075886
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.
Cobourne-Duval MK; Taka E; Mendonca P; Soliman KFA
J Neuroimmunol; 2018 Jul; 320():87-97. PubMed ID: 29759145
[TBL] [Abstract][Full Text] [Related]
7. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
8. Microarray analysis of gene expression profile by treatment of Cinnamomi Ramulus in lipopolysaccharide-stimulated BV-2 cells.
Hwang SH; Choi YG; Jeong MY; Hong YM; Lee JH; Lim S
Gene; 2009 Aug; 443(1-2):83-90. PubMed ID: 19422891
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.
Toniolo PA; Liu S; Yeh JE; Moraes-Vieira PM; Walker SR; Vafaizadeh V; Barbuto JA; Frank DA
J Immunol; 2015 Apr; 194(7):3180-90. PubMed ID: 25725100
[TBL] [Abstract][Full Text] [Related]
10. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury.
Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK
Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146
[TBL] [Abstract][Full Text] [Related]
11. RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitor.
Das A; Arifuzzaman S; Yoon T; Kim SH; Chai JC; Lee YS; Jung KH; Chai YG
Sci Rep; 2017 Jul; 7(1):6554. PubMed ID: 28747667
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome sequencing reveals that LPS-triggered transcriptional responses in established microglia BV2 cell lines are poorly representative of primary microglia.
Das A; Kim SH; Arifuzzaman S; Yoon T; Chai JC; Lee YS; Park KS; Jung KH; Chai YG
J Neuroinflammation; 2016 Jul; 13(1):182. PubMed ID: 27400875
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.
Suarez-Alvarez B; Morgado-Pascual JL; Rayego-Mateos S; Rodriguez RM; Rodrigues-Diez R; Cannata-Ortiz P; Sanz AB; Egido J; Tharaux PL; Ortiz A; Lopez-Larrea C; Ruiz-Ortega M
J Am Soc Nephrol; 2017 Feb; 28(2):504-519. PubMed ID: 27436852
[TBL] [Abstract][Full Text] [Related]
14. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.
Belkina AC; Nikolajczyk BS; Denis GV
J Immunol; 2013 Apr; 190(7):3670-8. PubMed ID: 23420887
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of BET protein BRD4 delays murine lupus.
Wei S; Sun Y; Sha H
Int Immunopharmacol; 2015 Dec; 29(2):314-319. PubMed ID: 26590112
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition.
Kremlev SG; Roberts RL; Palmer C
J Neuroimmunol; 2004 Apr; 149(1-2):1-9. PubMed ID: 15020059
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic intervention with a BET inhibitor ameliorates acute retinal ganglion cell death in mice.
Li J; Zhao L; Urabe G; Fu Y; Guo LW
Mol Vis; 2017; 23():149-159. PubMed ID: 28356707
[TBL] [Abstract][Full Text] [Related]
18. FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing.
Das A; Arifuzzaman S; Kim SH; Lee YS; Jung KH; Chai YG
Neuropharmacology; 2017 Jun; 119():1-14. PubMed ID: 28373076
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome sequencing of microglial cells stimulated with TLR3 and TLR4 ligands.
Das A; Chai JC; Kim SH; Lee YS; Park KS; Jung KH; Chai YG
BMC Genomics; 2015 Jul; 16(1):517. PubMed ID: 26159724
[TBL] [Abstract][Full Text] [Related]
20. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype.
Dirscherl K; Karlstetter M; Ebert S; Kraus D; Hlawatsch J; Walczak Y; Moehle C; Fuchshofer R; Langmann T
J Neuroinflammation; 2010 Jan; 7():3. PubMed ID: 20074346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
